Ledger.Open graph →
SEC Form D · filed October 2, 2023

Atsena Therapeutics, Inc

Offering
$32.0M
Sold
$24.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jacqueline Grant · Durham, NCDirectorJames Healy · Newtown Square, PADirectorPatrick Ritschel · Durham, NCExec · DirectorMichael Dial · Boston, MADirectorJennifer Wellman · Durham, NCDirectorShannon Boye · Durham, NCDirectorMichael Dial · Greenville, NCDirectorJudson K. Lacapra · VANCOUVER, British Columbia, CanadaDirectorCraig Murli · EMERYVILLE, CADirectorJames Healy · West Lebanon, NHDirectorGabriel K. Segal · VANCOUVER, British Columbia, CanadaExec · DirectorPatrick Ritschel · Durham, NCExec · DirectorJennifer Wellman · Durham, NCDirectorChristina Isacson · Durham, NCDirectorChristina Isacson · Durham, NCDirectorJacqueline Grant · Durham, NCDirectorElizabeth Leiderman · Durham, NCExecElizabeth Leiderman · Durham, NCExecShannon Boye · Durham, NCDirectorMatthew Romney · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗